Teriflunomide for treating relapsing–remitting multiple sclerosis

Technology appraisal guidance
Reference number: TA303
Published: 22 January 2014
Last updated: 01 June 2014

History

Documents created during the development process.

Background information

TA303 Multiple sclerosis (relapsing) - teriflunomide: press release information

Multiple sclerosis (relapsing) - teriflunomide: equality impact assessment - guidance review

Multiple sclerosis (relapsing) - teriflunomide: equality impact assessment - guidance review
Multiple sclerosis (relapsing) - teriflunomide: equality impact assessment - guidance review (PDF 18 KB)

Published:

23 January 2014

Multiple sclerosis (relapsing) - teriflunomide: final appraisal determination

Multiple sclerosis (relapsing) - teriflunomide: final appraisal determination information
Multiple sclerosis (relapsing) - teriflunomide: final appraisal determination
Multiple sclerosis (relapsing) - teriflunomide: final appraisal determination (PDF 218 KB)

Published:

06 December 2013
Multiple sclerosis (relapsing) - teriflunomide: evaluation report information
Multiple sclerosis (relapsing) - teriflunomide: evaluation report (PDF 1.84 MB)

Published:

06 December 2013

Multiple sclerosis (relapsing) - teriflunomide: appraisal consultation

Multiple sclerosis (relapsing) - teriflunomide: appraisal consultation
Multiple sclerosis (relapsing) - teriflunomide: appraisal consultation document information
Multiple sclerosis (relapsing) - teriflunomide: evaluation report information
Multiple sclerosis (relapsing) - teriflunomide: evaluation report (PDF 12.56 MB)

Published:

18 September 2013

Multiple sclerosis (relapsing) - teriflunomide: final scope

Multiple sclerosis (relapsing) - teriflunomide: final scope
Multiple sclerosis (relapsing) - teriflunomide: final scope (PDF 31 KB)

Published:

11 April 2013

Multiple sclerosis (relapsing) - teriflunomide: final matrix

Multiple sclerosis (relapsing) - teriflunomide: final matrix
Multiple sclerosis (relapsing) - teriflunomide: final matrix (PDF 32 KB)

Published:

11 April 2013

Multiple sclerosis (relapsing) - teriflunomide: provisional matrix - (pre referral) July 2012

Multiple sclerosis (relapsing) - teriflunomide: provisional matrix - (pre referral) July 2012
Multiple sclerosis (relapsing) - teriflunomide: provisional matrix - (pre referral) July 2012 (PDF 40 KB)

Published:

05 April 2013

Multiple sclerosis (relapsing) - teriflunomide: draft scope - (pre referral) July 2012

Multiple sclerosis (relapsing) - teriflunomide: draft scope - (pre referral) July 2012
Multiple sclerosis (relapsing) - teriflunomide: draft scope - (pre referral) July 2012 (PDF 112 KB)

Published:

05 April 2013

Multiple sclerosis (relapsing) - teriflunomide: provisional matrix - (pre referral) March 2012

Multiple sclerosis (relapsing) - teriflunomide: provisional matrix - (pre referral) March 2012
Multiple sclerosis (relapsing) - teriflunomide: provisional matrix - (pre referral) March 2012 (PDF 38 KB)

Published:

03 April 2013

Multiple sclerosis (relapsing) - teriflunomide: draft scope - (pre referral) March 2012

Multiple sclerosis (relapsing) - teriflunomide: draft scope - (pre referral) March 2012
Multiple sclerosis (relapsing) - teriflunomide: draft scope - (pre referral) March 2012 (PDF 102 KB)

Published:

03 April 2013